Period of time： 2008年1期
Publisher： Humana Press, Inc
Founded in： 2001
Total resources： 30
ISSN： 1530-7905
Subject： R5 Internal Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Cardiovascular Toxicology,volume 3,issue 1
Menu
Biotechnology-derived cardiovascular therapeutics and toxicity
Cardiovascular Toxicology,volume 3,issue 1 , Vol. 3, Iss. 1, 2003-03 , pp.
Access to resources
Recommend
Commercial development considerations for biotechnology-derived therapeutics
By Marafino B.,Pugsley M. in (2003)
Cardiovascular Toxicology,volume 3,issue 1 , Vol. 3, Iss. 1, 2003-03 , pp.Direct thrombin inhibitors in cardiac disease
By Weitz Jeffrey,Bates Eric in (2003)
Cardiovascular Toxicology,volume 3,issue 1 , Vol. 3, Iss. 1, 2003-03 , pp.Translation of PDGF cardioprotective pathways
By Edelberg Jay,Cai Dongqing,Xaymardan Munira in (2003)
Cardiovascular Toxicology,volume 3,issue 1 , Vol. 3, Iss. 1, 2003-03 , pp.Nesiritide: A new therapy for the treatment of heart failure
Cardiovascular Toxicology,volume 3,issue 1 , Vol. 3, Iss. 1, 2003-03 , pp.Inhibitors of the complement system currently in development for cardiovascular disease
By Pugsley M.,Abramova M.,Cole T.,Yang X.,Ammons W. in (2003)
Cardiovascular Toxicology,volume 3,issue 1 , Vol. 3, Iss. 1, 2003-03 , pp.